In an era of transforming technologies in molecular sequencing, imaging, and artificial intelligence, there is an urgent need for skilled researchers who can bridge the gap between biomedical and computational sciences.
At our ANU node, EMBL Australia group leader Professor Eduardo Eyras is Director of the ANU’s Centre for Computational Biomedical Sciences (CCBS), and focused on developing advanced computational and medical technologies to enable discovery and interpretation in biomedical research.
One game-changing initiative is the Talo Computational Biology Talent Accelerator, a pioneering program established with the help of a $2.5 million donation from biotech start-up Talo.
The initiative provides scholarships, courses and grants to provide top students and early-career researchers with the skills needed to tackle complex biomedical challenges and drive healthcare innovation.
In his research, Prof Eyras uses computational tools to study RNA and its role in cancer. His research focuses on developing new technologies to improve cancer treatments, understanding how cells change and resist therapy, and enhancing the analysis of genetic data for medicine and research.
With more than 43,000 citations, his work is widely recognised.
A passionate advocate for knowledge-sharing, Prof Eyras actively contributes to EMBL Australia training programs and recently spoke at the 5th EMBL Partnership Conference on ‘AI in One Health’.